BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 236 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,466 | -28.6% | 207,095 | -29.0% | 0.07% | -22.5% |
| Q2 2023 | $2,053 | -5.7% | 291,556 | +11.7% | 0.09% | -13.6% |
| Q1 2023 | $2,177 | +20.1% | 260,986 | +65.2% | 0.10% | +3.0% |
| Q4 2022 | $1,813 | -99.9% | 157,944 | +62.6% | 0.10% | +35.1% |
| Q3 2022 | $1,224,000 | +48.4% | 97,127 | +24.5% | 0.07% | +19.4% |
| Q2 2022 | $825,000 | -25.5% | 77,988 | +14.5% | 0.06% | -15.1% |
| Q1 2022 | $1,108,000 | +298.6% | 68,114 | +239.6% | 0.07% | +108.6% |
| Q4 2021 | $278,000 | -3.5% | 20,056 | 0.0% | 0.04% | -7.9% |
| Q3 2021 | $288,000 | – | 20,056 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |